Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_06-cv-01361/USCOURTS-cand-3_06-cv-01361-7/pdf.json

Parties Involved:
Mark J. Murray
Defendant
Protiva Biotherapeutics, Inc.
Defendant
Sirna Therapeutics, Inc.
Plaintiff

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

US_WEST:260095175.1 SECOND RE-NOTICE OF MOTION 

CASE NO.: C 06-01361 MMC

ELIZABETH A. HOWARD (SBN 173185) ehoward@orrick.com

JAN E. ELLARD (SBN 171947) jellard@orrick.com

ORRICK, HERRINGTON & SUTCLIFFE LLP 

1000 Marsh Road 

Menlo Park, CA 94025 

Telephone: 650-614-7400 

Facsimile: 650-614-7401 

Attorneys for Defendants, 

PROTIVA BIOTHERAPEUTICS, INC. and 

MARK J. MURRAY 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

SIRNA THERAPEUTICS, INC., 

Plaintiff, 

v.

PROTIVA BIOTHERAPEUTICS, INC. and 

MARK J. MURRAY, 

Defendants.

Case No. C 06-01361 MMC 

DEFENDANTS PROTIVA 

BIOTHERAPEUTICS, INC.’S AND 

MARK J. MURRAY’S SECOND RENOTICE OF MOTION TO DISMISS 

PLAINTIFF’S AMENDED 

COMPLAINT PURSUANT TO 

FEDERAL RULE OF CIVIL 

PROCEDURE 12(b)(7), TO STAY 

THIS CASE PURSUANT TO 

ABSTENTION DOCTRINE, AND TO 

DISMISS PLAINTIFF’S FRAUD 

CLAIM PURSUANT TO FEDERAL 

RULE OF CIVIL PROCEDURE 

12(b)(6)

Date: November 17, 2006 

Time: 9:00 a.m. 

Judge: Honorable Maxine M. Chesney 

Place: Courtroom 7, 19th Floor 

Dated: September 21, 2006

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

IT IS SO ORDERED

Judge Maxine M. Chesney

Case 3:06-cv-01361-MMC Document 31 Filed 09/21/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

US_WEST:260095175.1 -1- SECOND RE-NOTICE OF MOTION 

CASE NO.: C 06-01361 MMC

RE-NOTICED NOTICE OF MOTION

On November 17, 2006, at 9:00 a.m. (or as soon thereafter as the matter may be 

heard) in Courtroom 7 of the United States District Court for the Northern District of California, 

defendants Protiva Biotherapeutics, Inc. (“Protiva”) and Mark J. Murray (“Dr. Murray”) will and 

hereby do move this Court to enter an Order dismissing the Amended Complaint of plaintiff Sirna 

Therapeutics, Inc. (“Sirna”) or staying this action pending the resolution of the state court action 

between Protiva and Sirna following the Colorado River abstention doctrine. This Motion was 

originally noticed for October 27, 2006, and subsequently re-noticed for November 3, 2006. It is 

now being re-noticed to accommodate the schedule of all the parties and their counsel. This 

Motion is based upon this re-noticed notice of motion, and the before-filed Motion, Memorandum 

of Points and Authorities attached thereto and filed therewith, the Declaration of Elizabeth A. 

Howard, Affidavit of Dr. Mark J. Murray filed in support of the Motion, the complete files and 

records in this action, all matters of which the Court may take judicial notice, and any and all 

documentary evidence or oral argument as may be presented in conjunction with the hearing in 

this motion 

Dismissal of the action is warranted because Sirna failed to join Protiva 

Biotherapeutics USA, Inc., an indispensable party that destroys diversity jurisdiction, which is the 

basis for this Court’s subject matter jurisdiction over this matter. Further, a stay is warranted 

following the Colorado River abstention doctrine because of pending state court actions between 

Protiva and Sirna, and between Protiva and Inex Pharmaceuticals, Corp., involving a near identity 

of issues. In addition, Sirna’s fraud claim should be dismissed with prejudice as Sirna failed to 

plead (nor can it plead) all the elements of fraud in its Amended Complaint. 

Dated: September 21, 2006 Orrick, Herrington & Sutcliffe LLP 

/s/ Elizabeth A. Howard 

Elizabeth A. Howard 

Attorneys for Defendants, 

PROTIVA BIOTHERAPEUTICS, INC. and 

MARK J. MURRAY 

Case 3:06-cv-01361-MMC Document 31 Filed 09/21/06 Page 2 of 2